Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
6417.5000 -5.00 (-0.08%)
NSE Dec 02, 2025 15:31 PM
Volume: 151.9K
 

6417.50
-0.08%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenue grew 4% YoY to | 1005 crore (I-direct estimate: | 1090 crore) mainly due to 35% YoY growth in Carotenoids business to...
Number of FII/FPI investors decreased from 990 to 897 in Sep 2025 qtr
More from Divi's Laboratories Ltd.
Recommended